Perspective Therapeutics (CATX) 10-Q2008 Q4 Quarterly report

Filed: 17 Feb 09, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: AG, agent, Anthony, Atomic, attached, calendar, CE, credibility, deposited, Disposal, disposition, Distributor, domestic, entail, extent, factor, familiar, felt, flow, foreign, implant, INM, instrument, lawsuit, listing, maintenance, minimum, nominal, Nuclear, overhaul, Pasqualone, pertaining, phase, physician, pressure, prototype, put, receipt, reclassification, recruiting, reduction, reimbursement, reluctant, responsible, revamp, revamping, RIAR, significantly, thirty, trend, UBS, write

Removed: authorized, began, behalf, Chief, consummate, corporation, duly, EITF, expiration, expire, expiring, extended, extension, government, Hunt, Jonathan, Minnesota, missed, modification, offering, ordered, placement, retroactively, thereunto, transaction, undersigned, viewed, warrant

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

CATX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

Section 1350 Certifications

Pursuant to 18 U.S.C. § 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of IsoRay, Inc., a Minnesota corporation (the "Company"), hereby certify that:

To my knowledge, the Quarterly Report on Form 10-Q of the Company for the quarterly period ended December 31, 2008 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 17, 2009

		/s/ Dwight Babcock
		DWIGHT BABCOCK
		INTERIM CHIEF EXECUTIVE OFFICER

Dated: February 17, 2009

		/s/ Jonathan R. Hunt
		JONATHAN R. HUNT
		CHIEF FINANCIAL OFFICER